A Study of Cisplatin or Carboplatin With Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Patients With Resected or Ablation Intra-Hepatic Cholangiocarcinoma

NCT03081039 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Competing study

Conditions

Intrahepatic Cholangiocarcinoma

Interventions

DRUG: Carboplatin
DRUG: Cisplatin
DRUG: Gemcitabine

Sponsor

University of Louisville